Monoclonal antibody CC49 I-131 (Corixa)

N/A

Report date: 2025/11/24 17:27:59

Base Information

Drug NameMonoclonal antibody CC49 I-131 (Corixa)

Drug Alias NameI-131 monoclonal antibody CC49Monoclonal antibody I-131 CC49

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineRadiation-emitting products > Radioactive therapeutic agent +[5]

Mechanisms of ActionTumor-associated glycoprotein 72 inhibitors

TargetsTumor-associated glycoprotein 72

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCorixa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCorixa

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A